SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-19-008816
Filing Date
2019-02-14
Accepted
2019-02-14 17:00:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a19-4787_1sc13ga.htm SC 13G/A 56876
  Complete submission text file 0001104659-19-008816.txt   58326
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88833 | Film No.: 19607936
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address LASHFORD HOUSE, CHURCH LANE DRY SANDFORD ABINGDON, OXFORDSHIRE X0 OX13 6JP
Business Address
Cross Nicholas John (Filed by) CIK: 0001669945 (see all company filings)

Type: SC 13G/A